Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non‐Muscle Invasive Bladder Cancer: Real‐World Incidence and Concomitant Medication Effects

Key Points

• The study aims to assess the incidence of skin phototoxicity associated with aminolevulinic acid hydrochloride in bladder cancer treatment.
• Analyzed real-world cases of skin phototoxicity in patients undergoing photodynamic diagnosis-assisted procedures.
• Reviewed medication lists for potential photosensitizing agents and monitored alanine aminotransferase levels.
• Implemented light-avoidance measures for patient safety.
• Skin phototoxicity is uncommon and mild in patients using aminolevulinic acid hydrochloride.
• Use of photosensitizing medications correlates with an increased risk of phototoxicity.
• Standard light-avoidance measures alongside medication reviews help mitigate risk.